Effects of Inflammatory Factor Expression Regulated by 12/15 Lipoxygenase on Obesity-Related Nephropathy

Overview

Journal Nutrients

Date 2022 Jul 9

PMID 35807921

Authors

Nian Liu

Yang Liu

Dan Dong

Jinyu Yu

Hang Yuan

Affiliations

Soon will be listed here.

Abstract

Background: It has been demonstrated that 12/15-lipoxygenase (LO) contributes to insulin resistance by promoting beta cells' exposure to inflammation. We investigate the mechanism by which 12/15-LO regulates the expression of inflammatory factors in obesity-related glomerular disease (ORG).

Methods: Glomerular mesangial cells were treated with metabolite of 12/15-LO, and the expression of inflammatory factors was measured. Cell histones methylation in 12/15-LO related metabolic memory process were evaluated by chromatin immunoprecipitation (ChIP) assays. Wild-type (WT) and 12/15-LO knockout mice were fed a high-fat diet (HFD) to induce ORG.

Results: 12(S)-HETE increased TNF-α, MCP-1, and IL-6 mRNA expression. Inhibition of 12/15-LO reduced the expression of inflammatory factors stimulated by PA or TNF-α. ChIP assays showed that 12(S)-HETE increased H3K4me modification in the TNF-α, IL-6, and MCP-1 gene promoters, and decreased H3K9me3 modification in the MCP-1 and IL-6 gene promoter. Urinary albumin excretion was greater in HFD-fed than in standard fat diet-fed mice, but both urinary protein and microalbumin amounts were lower in HFD-fed 12/15-LO knockout than in WT mice. The levels of TNF-α, IL-6, and MCP-1 in serum and renal cortex were higher in WT than in 12/15-LO knockout mice.

Conclusions: 12/15-LO may regulate the expression of inflammatory factors in ORG by methylation of histones in the promoter regions of genes encoding inflammatory factors, sustaining the inflammatory phenotype of ORG.

Citing Articles

Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications.

Cai L Nutrients. 2023; 15(11).

PMID: 37299478 PMC: 10255908. DOI: 10.3390/nu15112515.

References

Xu H, Cheng Y, Wang W, Wu H, Zhang Y, Zang C . 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance. Int J Mol Sci. 2016; 17(5). PMC: 4881510. DOI: 10.3390/ijms17050684. View

Decleves A, Zolkipli Z, Satriano J, Wang L, Nakayama T, Rogac M . Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury. Kidney Int. 2013; 85(3):611-23. PMC: 4244908. DOI: 10.1038/ki.2013.462. View

Chakrabarti S, Wen Y, Dobrian A, Cole B, Ma Q, Pei H . Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats. Am J Physiol Endocrinol Metab. 2010; 300(1):E175-87. PMC: 3023204. DOI: 10.1152/ajpendo.00203.2010. View

Roubicek T, Bartlova M, Krajickova J, Haluzikova D, Mraz M, Lacinova Z . Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Nutrition. 2009; 25(7-8):762-8. DOI: 10.1016/j.nut.2008.12.012. View

Villeneuve L, Reddy M, Lanting L, Wang M, Meng L, Natarajan R . Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A. 2008; 105(26):9047-52. PMC: 2449362. DOI: 10.1073/pnas.0803623105. View

Tersey S, Maier B, Nishiki Y, Maganti A, Nadler J, Mirmira R . 12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets. Mol Cell Biol. 2014; 34(19):3735-45. PMC: 4187733. DOI: 10.1128/MCB.00157-14. View

Li Y, Reddy M, Miao F, Shanmugam N, Yee J, Hawkins D . Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem. 2008; 283(39):26771-81. PMC: 2546554. DOI: 10.1074/jbc.M802800200. View

Stienstra R, van Diepen J, Tack C, Zaki M, van de Veerdonk F, Perera D . Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A. 2011; 108(37):15324-9. PMC: 3174591. DOI: 10.1073/pnas.1100255108. View

Lopategi A, Lopez-Vicario C, Alcaraz-Quiles J, Garcia-Alonso V, Rius B, Titos E . Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction. Mol Cell Endocrinol. 2015; 419:44-59. DOI: 10.1016/j.mce.2015.09.033. View

10.

Rosen E, Kaestner K, Natarajan R, Patti M, Sallari R, Sander M . Epigenetics and Epigenomics: Implications for Diabetes and Obesity. Diabetes. 2018; 67(10):1923-1931. PMC: 6463748. DOI: 10.2337/db18-0537. View

11.

Miao F, Chen Z, Genuth S, Paterson A, Zhang L, Wu X . Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes. 2014; 63(5):1748-62. PMC: 3994951. DOI: 10.2337/db13-1251. View

12.

Tersey S, Bolanis E, Holman T, Maloney D, Nadler J, Mirmira R . Minireview: 12-Lipoxygenase and Islet β-Cell Dysfunction in Diabetes. Mol Endocrinol. 2015; 29(6):791-800. PMC: 4447641. DOI: 10.1210/me.2015-1041. View

13.

Sethi J, Hotamisligil G . Metabolic Messengers: tumour necrosis factor. Nat Metab. 2021; 3(10):1302-1312. DOI: 10.1038/s42255-021-00470-z. View

14.

Ziyadeh F, Wolf G . Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008; 4(1):39-45. DOI: 10.2174/157339908783502370. View

15.

Faulkner J, Pye C, Al-Shabrawey M, Elmarakby A . Inhibition of 12/15-Lipoxygenase Reduces Renal Inflammation and Injury in Streptozotocin-Induced Diabetic Mice. J Diabetes Metab. 2016; 6(6). PMC: 4727755. DOI: 10.4172/2155-6156.1000555. View

16.

Hernandez-Perez M, Chopra G, Fine J, Conteh A, Anderson R, Linnemann A . Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes. Diabetes. 2017; 66(11):2875-2887. PMC: 5652601. DOI: 10.2337/db17-0215. View

17.

Yeung J, Holinstat M . 12-lipoxygenase: a potential target for novel anti-platelet therapeutics. Cardiovasc Hematol Agents Med Chem. 2011; 9(3):154-64. PMC: 3171607. DOI: 10.2174/187152511797037619. View

18.

Cui Y, Liu N, Ma F, Sun W, Wu H, Xu Z . Role of histone modification in 12‑lipoxygenase‑associated p21 gene regulation. Mol Med Rep. 2016; 14(4):3978-84. DOI: 10.3892/mmr.2016.5724. View

19.

Ma K, Nunemaker C, Wu R, Chakrabarti S, Taylor-Fishwick D, Nadler J . 12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets. J Clin Endocrinol Metab. 2010; 95(2):887-93. PMC: 2840856. DOI: 10.1210/jc.2009-1102. View

20.

Dobrian A, Morris M, Taylor-Fishwick D, Holman T, Imai Y, Mirmira R . Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications. Pharmacol Ther. 2018; 195:100-110. PMC: 6397662. DOI: 10.1016/j.pharmthera.2018.10.010. View